Clinical Edge Journal Scan

MetS linked to increased risk for low BMD in women with suspected osteoporosis


 

Key clinical point: Metabolic syndrome (MetS) is associated with an increased risk for low bone mineral density (BMD) in women examined by dual-energy X-ray absorptiometry (DXA) for suspected osteoporosis .

Major finding: MetS was associated with an increased risk for low BMD (odds ratio [OR], 1.19; P = .001). Among MetS components, hypertension significantly correlated with an increased risk for low BMD (OR, 1.23; P = .002), whereas high fasting glucose level/diabetes correlated with a reduced occurrence of low BMD (OR, 0.84; P = .003).

Study details: The data come from a cross-sectional study of 13,182 free-living Caucasian women in Italy (mean age, 62.8 years) who underwent diagnostic assessment of BMD by DXA and of all MetS constitutive elements.

Disclosures: This study received no external funding. The authors declared no conflicts of interest.

Citation: Rendina D et al. J Endocrinol Invest. 2020 Sep 22. doi: 10.1007/s40618-020-01428-w .

Recommended Reading

Osteoporosis Journal Scans: October 2020
MDedge Rheumatology
Low DHT linked to hip fracture in men
MDedge Rheumatology
Burosumab is a ‘game changer,’ effective in all subgroups of XLH
MDedge Rheumatology
Combine calculators and medications to manage risk in osteoporosis patients
MDedge Rheumatology
Vertebral fractures in COVID-19 linked to mortality
MDedge Rheumatology
Treatment sequence with romosozumab influences osteoporosis outcomes
MDedge Rheumatology
Osteoporosis underdiagnosed in older men with fracture
MDedge Rheumatology
Denosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosis
MDedge Rheumatology
Age-related macular degeneration tied to fracture risk in patients with osteoporosis
MDedge Rheumatology
Serum vitamin K1 inversely related to fracture risk in postmenopausal osteoporosis
MDedge Rheumatology